SCHEMBL1725997

SCHEMBL1725997

CCC(C)CN1c2nc[nH]c(=O)c2NC1c1cnn(Cc2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 17/20 0.41
ADORA2A P29274 13/20 0.41
ADORA1 P30542 12/20 0.41
ADORA3 P0DMS8 11/20 0.41
ALK Q9UM73 1/20 0.40
PLK4 O00444 1/20 0.37
CDK2 P24941 1/20 0.37
IRAK1 P51617 1/20 0.37
RPS6KA3 P51812 1/20 0.37
PLK3 Q9H4B4 1/20 0.37
CSNK1G3 Q9Y6M4 1/20 0.37
KDM4A O75164 1/20 0.34
KDM4B O94953 1/20 0.34
KDM5C P41229 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
P2RX7 Q99572 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15642923 0.94 ADORA2B (0.41) ADORA2BADORA2AADORA1ADORA3ALK
SCHEMBL1725995 0.73 ADORA2B (0.50) ADORA2BADORA2AADORA1ADORA3ALK
SCHEMBL1697136 0.71 ADORA2B (0.47) ADORA2BADORA2AADORA1ADORA3ALK
SCHEMBL27866608 0.71 ALK (0.42) ADORA2BADORA2AADORA1ADORA3ALK
SCHEMBL7487274 0.66 PARP1 (0.45) ALK
SCHEMBL1725999 0.66 ADORA2B (0.62) ADORA2BADORA2AADORA1ADORA3PLK4
SCHEMBL27063234 0.65 ADORA2B (0.60) ADORA2BADORA2AADORA1ADORA3PLK4
SCHEMBL5685834 0.63 ADORA2B (0.45) ADORA2BADORA2AADORA1ADORA3ALK
SCHEMBL27866609 0.62 ADORA2B (0.50) ADORA2BADORA2AADORA1ADORA3ALK
SCHEMBL24214370 0.61 ALDH1A1 (0.55) ADORA2BADORA2AADORA1ADORA3ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2405917-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS Advinus Therapeutics Private Limited (IN) 2012-01-18 EP disclosed
WO-2010103547-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2010-09-16 WO disclosed